SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-105890
Filing Date
2024-04-23
Accepted
2024-04-23 07:05:49
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d448465ddefa14a.htm DEFA14A 22187
2 GRAPHIC g448465dsp3d.jpg GRAPHIC 4880
3 GRAPHIC g448465dsp4a.jpg GRAPHIC 10493
4 GRAPHIC g448465dsp4b.jpg GRAPHIC 23637
5 GRAPHIC g448465dsp4c.jpg GRAPHIC 47913
6 GRAPHIC g448465dsp4e.jpg GRAPHIC 3008
7 GRAPHIC g448465dsp4f.jpg GRAPHIC 2563
8 GRAPHIC g448465dsp4g.jpg GRAPHIC 1822
9 GRAPHIC g448465dsp4h.jpg GRAPHIC 5854
  Complete submission text file 0001193125-24-105890.txt   162363
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39103 | Film No.: 24862673
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)